Skip to main content

Latest news! First Impact factor received: 2.9

Latest news! First Impact factor received: 2.9We are pleased to share that Journal of Ophthalmic Inflammation and Infection has received its first Impact Factor of 2.9 in the Journal Citation Reports™ (Clarivate) in June 2023.

Congratulations to the Editors and Editorial board!

The journal would like to thank all of our authors, reviewers, editors and readers for their continued support.

Collection: Intraocular vasculitis

Following the incitement of the chief-editor, Carlos Pavesio, to initiate a special issue of the Journal of Ophthalmic Inflammation and Infection (JOII) on intraocular vasculitis, I felt it was worth initiating such a venture at this time and act as guest-editor. Indeed, the recent advances in the knowledge and the investigational modalities of intraocular vasculitis that became available certainly justify such an undertaking. We are encouraging colleagues interested and active in this domain to submit original or review work as well as cases and case series on the topic. To help in this task three other guest co-editors accepted to take part in this project, including Vishali Gupta from India, Ioannis Papasavvas from Switzerland and Ilknur Tugal-Tutkun from Turkey. We are looking forward to valuable contributions towards a successful project and advancement of medical knowledge.


  1. Authors: Nikolas JS London, Sunir J Garg, Ramana S Moorthy and Emmett T Cunningham Jr

Call for Papers: Anterior segment inflammation highlights update

The Journal of Ophthalmic inflammation and Infection invites participating authors to submit to our Collection on Anterior segment inflammation highlights update Guest Edited by Jorge L. Alió, Andrea Leonardi, and Uwe Pleyer.

Collection: Updates and glimpses on non-infectious and/or immune induced choroiditis

Exploration of the choroid has become more performing in the last 2-3 decades with the development of powerful imaging methods. In the light of such new precise investigational possibilities the topic of non-infectious / immune mediated  inflammation of the choroid is explored addressing the anatomy and immunology of the choroid, investigational approach of choroiditis and diagnosis, appraisal and therapy of specific choroiditis entities.

Aims and scope

The Journal of Ophthalmic Inflammation and Infection is a peer-reviewed open access journal published under the brand SpringerOpen. It presents current clinical and experimental research on a range of ophthalmic inflammation and infection topics.

Coverage includes original studies, review articles, brief reports, case reports, photo essays, and expert commentary on challenging cases. The journal reflects geographical variations in incidence of diseases as well as different treatment modalities worldwide.

This is the official journal of the International Ocular Inflammation Society (IOIS), and the editorial board includes international experts in the field of ophthalmic inflammation and infection.

Important for Authors

If you are based in GermanyHungarySweden, you may publish your article open access with your fees covered by your institution. Check the list of eligible institutions that are included in the agreements.

Go through the Journal submission guidelines and learn about Fees and funding options 

Check if your institution has partnered with Springer Nature through the membership program 

Visit Springer Nature OA funding and policy support page  to view the list of research funders and institutions that provide funding for article processing charges.

Society affiliation

Journal of Ophthalmic Inflammation and Infection is published in cooperation with the International Ocular Inflammation Society. The Society will cover the article processing charges for selected invited articles published in Journal of Ophthalmic Inflammation and Infection. 

Annual Journal Metrics

  • 2022 Citation Impact
    2.9 - 2-year Impact Factor
    2.9 - 5-year Impact Factor
    1.381 - SNIP (Source Normalized Impact per Paper)
    0.607 - SJR (SCImago Journal Rank)

    2023 Speed
    8 days submission to first editorial decision for all manuscripts (Median)
    116 days submission to accept (Median)

    2023 Usage
    274 Altmetric mentions